148 related articles for article (PubMed ID: 1695606)
21. Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies.
Bröker BM; Klajman A; Youinou P; Jouquan J; Worman CP; Murphy J; Mackenzie L; Quartey-Papafio R; Blaschek M; Collins P
J Autoimmun; 1988 Oct; 1(5):469-81. PubMed ID: 2473761
[TBL] [Abstract][Full Text] [Related]
22. Intraclonal diversity in the VH genes expressed by CD5- chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor.
Roudier J; Silverman GJ; Chen PP; Carson DA; Kipps TJ
J Immunol; 1990 Feb; 144(4):1526-30. PubMed ID: 1689356
[TBL] [Abstract][Full Text] [Related]
23. Mouse erythrocyte rosette formation with malignant human B-lymphocytes re-evaluated: still a useful marker for differentiating mature B-cell malignancies.
Hokland P; Geisler CH; Andersen E; Drivsholm A; Hansen MM; Meyer K
Br J Haematol; 1992 Nov; 82(3):560-4. PubMed ID: 1283079
[TBL] [Abstract][Full Text] [Related]
24. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
[TBL] [Abstract][Full Text] [Related]
25. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
Roliński J; Rupniewska ZM; Wasik-Szczepanek E
Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
[TBL] [Abstract][Full Text] [Related]
26. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.
Damle RN; Ghiotto F; Valetto A; Albesiano E; Fais F; Yan XJ; Sison CP; Allen SL; Kolitz J; Schulman P; Vinciguerra VP; Budde P; Frey J; Rai KR; Ferrarini M; Chiorazzi N
Blood; 2002 Jun; 99(11):4087-93. PubMed ID: 12010811
[TBL] [Abstract][Full Text] [Related]
27. Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.
Gale RP; Caligaris-Cappio F; Dighiero G; Keating M; Montserrat E; Rai K
Leukemia; 1994 Sep; 8(9):1610-4. PubMed ID: 7522296
[TBL] [Abstract][Full Text] [Related]
28. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
Shokri F; Mageed RA; Richardson P; Jefferis R
Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and functional features of CD5+ B lymphocytes in rheumatoid arthritis.
Plater-Zyberk C; Maini RN
Scand J Rheumatol Suppl; 1988; 75():76-83. PubMed ID: 2467354
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotype analysis of B-CLL lymphoma and immunocytoma.
Martinsson U; Sundström C; Glimelius B
APMIS; 1989 Nov; 97(11):1025-32. PubMed ID: 2531599
[TBL] [Abstract][Full Text] [Related]
31. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
32. [Chronic cold agglutinin disease accompanied with an increase of CD20+/CD5+ cells; a case report].
Notoya A; Hirayama S; Takano H; Koizumi K; Satoh N; Yasukouchi T; Sawada K; Koike T
Rinsho Ketsueki; 1994 Sep; 35(9):881-5. PubMed ID: 7526015
[TBL] [Abstract][Full Text] [Related]
33. Feedback suppression of normal and leukemic B cell colony growth by CD5+ B cells.
Fernandez LA; MacSween JM; Robson DA
Ann N Y Acad Sci; 1991; 628():379-81. PubMed ID: 1712559
[No Abstract] [Full Text] [Related]
34. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic heterogeneity of B- and T-cell differentiation antigens in B-CLL.
Merle-Beral H; Blanc C; Chastang C; Debre P
Eur J Haematol; 1988 Sep; 41(3):197-203. PubMed ID: 3263283
[TBL] [Abstract][Full Text] [Related]
36. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia.
Mayer R; Logtenberg T; Strauchen J; Dimitriu-Bona A; Mayer L; Mechanic S; Chiorazzi N; Borche L; Dighiero G; Mannheimer-Lory A
Blood; 1990 Apr; 75(7):1518-24. PubMed ID: 1690580
[TBL] [Abstract][Full Text] [Related]
37. Immunoregulatory capability of murine CLL-like CD5+ B cells.
Phillips J; Raveché E
Ann N Y Acad Sci; 1992 May; 651():488-90. PubMed ID: 1376068
[TBL] [Abstract][Full Text] [Related]
38. T cells and CD45R expression in B-chronic lymphocytic leukemia.
Briggs PG; Kraft N; Atkins RC
Leuk Res; 1990; 14(2):155-9. PubMed ID: 2138239
[TBL] [Abstract][Full Text] [Related]
39. CD5 antigen expression in B cell chronic lymphocytic leukaemia.
Brohée D; Cauchie P; Nève P
Med Oncol; 1994; 11(3-4):137-8. PubMed ID: 7543349
[No Abstract] [Full Text] [Related]
40. Expression of CD45 isoforms in chronic B-cell leukaemias.
Zola H; Siderius N; Flego L; Sparrow R; van der Weyden MB; Nimmo J; Hart DN; Houghton S; Boyd AW
Leuk Res; 1993 Mar; 17(3):209-16. PubMed ID: 7680734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
